BOSTON - Lowell E. Schnipper, MD, an internationally renowned leader in hematology-oncology, has been named Clinical Director of the Beth Israel Deaconess Medical Center Cancer Center.
Schnipper, who has been BIDMC's Division Chief of Hematology-Oncology in the Department of Medicine since 1974 - the only person to hold that position - will lead the integration and coordination of BIDMC's clinical care and clinical research for all types of cancers.
"Lowell will be working with the department chairs and our partners in the community to ensure that each of our cancer programs and multidisciplinary clinics functions effectively to provide the highest level of tertiary and secondary care and offer rapid access to clinical, investigational and psychological support services," said Lewis Cantley, PhD, the Cancer Center's Director.
"He will focus on the center's mission to deliver a superb patient experience, where all clinical entities - radiology, pathology, medical oncology, radiation oncology, surgical oncology, social work, psychiatry, physical therapy, genetic counseling, clinical research and other ancillary services - are aligned to meet the needs of our patients."
"There are few institutions in the nation so well prepared as BIDMC to make important strides in the field of cancer," said Schnipper. "BIDMC possesses unique skills inherent in our world-renowned research community coupled with coordinated care from extraordinary clinicians in the service of individualized medicine. Our hallmark for the future will be cancer diagnostics and therapy that is at the leading edge of medical science and technology, rendered with precision, safety and utmost respect for our patients and those close to them."
Schnipper is currently the Theodore and Evelyn Berenson Professor of Medicine at Harvard Medical School. His personal research interests and contributions have been in the fields of anti-viral and anti-neoplastic drug development, genomic instability of cancer, and clinical investigations into novel cancer therapies.
His leadership has spawned the development of 65 clinicians and scientists who have built nationally prominent programs in molecular imaging aimed at identifying cancer at its most minimal stage, understanding the origins of leukemia, and translational research in tumor vaccines, melanoma, kidney and prostate cancer.
"This appointment comes at a critical time in the delivery of cancer care, "said BIDMC President & CEO Kevin Tabb, MD. "Through our partnership with Commonwealth Hematology-Oncology, BIDMC now has the largest network of community-based cancer services in the state. Soon, we will break ground on a new state-of-the-art cancer center at Beth Israel Deaconess Hospital-Needham, which will allow us to provide the same level of care at a location convenient for our patients.
"Over the past four decades, Dr. Schnipper has been instrumental in building BIDMC's reputation as a leading cancer center that provides each of its patients the kind of care that each of us would want for our family members. We have no doubt that he will bring his trademark passion and clinical excellence to the entire Cancer Center."
Schnipper earned his medical degree from Downstate College of Medicine and the State University of New York, summa cum laude, and his BA from Queens College in New York. Among his professional and academic associations, he is Associate Director for Membership and Deputy Associate Director for Clinical Services for the Dana-Farber Harvard Cancer Center (DFHCC); has been a member of the national board of directors of the American Cancer Society and president of its Massachusetts division.
Schnipper is the recipient of the St. George Medal from the American Cancer Society, its highest award given to a volunteer, and the Distinguished Public Service Award from the American Society of Clinical Oncology. He has had, and currently holds leadership positions in the American Society of Clinical Oncology. Lowell has been repeatedly named a "Best Doctor" by
Boston Magazine, and is listed in "Best Doctors in America."
Beth Israel Deaconess Medical Center is a patient care, teaching and research affiliate of Harvard Medical School, and currently
ranks third in National Institutes of Health funding among independent hospitals nationwide. BIDMC is clinically affiliated with the Joslin Diabetes Center and is a research partner of Dana-Farber/Harvard Cancer Center. BIDMC is the official hospital of the Boston Red Sox. For more information, visit